Regulation of the vitamin D receptor gene by environment, genetics and epigenetics

Gene

Volumn 561, Issue 2, 2015, Pages 171-180

  Saccone, Donovan ^a   Asani, Furaha ^a   Bornman, Liza ^a  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

Environment; Epigenetic; Genetic; Regulation; VDR; Vitamin D

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA; UNTRANSLATED RNA; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

DNA METHYLATION; ENHANCER REGION; ENVIRONMENT; EPIGENETICS; GENE CONTROL; GENE STRUCTURE; GENETIC STABILITY; GENETICS; HISTONE MODIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENOTYPE ENVIRONMENT INTERACTION; METABOLISM; SUNLIGHT;

ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; HUMANS; RECEPTORS, CALCITRIOL; SUNLIGHT;

EID: 84926157398     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.02.024     Document Type: Review

References (87)

1. Agarwal K.S., Mughal M.Z., Upadhyay P., Berry J.L., Mawer E.B., Puliyel J.M. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch. Dis. Child. 2002, 87:111-113.
2. Ahn J., Yu K., Stolzenberg-Solomon R., Simon K.C., McCullough M.L., Gallicchio L., Jacobs E.J., Ascherio A., Helzlsouer K., Jacobs K.B., Li Q., Weinstein S.J., Purdue M., Virtamo J., Horst R., Wheeler W., Chanock S., Hunter D.J., Hayes R.B., Kraft P., Albanes D. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 2010, 19:2739-2745.
3. Andraos C., Koorsen G., Knight J.C., Bornman L. Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis and TaqI polymorphism. Hum. Immunol. 2011, 72:262-268.
4. Andress D.L. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006, 69:33-43.
5. Arai H., Miyamoto K., Taketani Y., Yamamoto H., Iemori Y., Morita K., Tonai T., Nishisho T., Mori S., Takeda E. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner. Res. 1997, 12:915-921.
6. Arai H., Miyamoto K.I., Yoshida M., Yamamoto H., Taketani Y., Morita K., Kubota M., Yoshida S., Ikeda M., Watabe F., Kanemasa Y., Takeda E. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J. Bone Miner. Res. 2001, 16:1256-1264.
7. Baker M. Long noncoding RNAs: the search for function. Nat. Methods 2011, 8:379-383.
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
9. Bjornsson H.T., Fallin M.D., Feinberg A.P. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 2004, 20:350-358.
10. Bock C., Walter J., Paulsen M., Lengauer T. CpG island mapping by epigenome prediction. PLoS Comput. Biol. 2007, 3:e110.
11. Carlberg C. Genome-wide (over)view on the actions of vitamin D. Front. Physiol. 2014, 5:167.
12. Chandel N., Husain M., Goel H., Salhan D., Lan X., Malhotra A., McGowen J., Singhal P.C. VDR hypermethylation and HIV-induced T-cell loss. J. Leukoc. Biol. 2013, 93:623-631.
13. Chen K., DeLuca H.F. Cloning of the human 1α, 25dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim. Biophys. Acta 1995, 1263:1-9.
14. Chen Z.X., Riggs A.D. DNA methylation and demethylation in mammals. J. Biol. Chem. 2011, 286:18347-18353.
15. Cheng J.B., Levine M.A., Bell N.H., Mangelsdorf D.J., Russell D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7711-7715.
16. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., Boyer L.A., Young R.A., Jaenisch R. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21931-21936.
17. Crofts L.A., Hancock M.S., Morrison N.A., Eisman J.A. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10529-10534.
18. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80:1689S-1696S.
19. Ding N., Yu R.T., Subramaniam N., Sherman M.H., Wilson C., Rao R., Leblanc M., Coulter S., He M., Scott C., Lau S.L., Atkins A.R., Barish G.D., Gunton J.E., Liddle C., Downes M., Evans R.M. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013, 153:601-613.
20. Essa S., Denzer N., Mahlknecht U., Klein R., Collnot E.M., Tilgen W., Reichrath J. VDR microRNA expression and epigenetic silencing of vitamin D signalling in melanoma cells. J. Steroid Biochem. Mol. Biol. 2010, 121:110-113.
21. Essa S., Reichrath S., Mahlknecht U., Montenarh M., Vogt T., Reichrath J. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Anticancer Res. 2012, 32:383-390.
22. Fang Y., van Meurs J.B.J., d'Alesio A., Jhamai M., Zhao H., Rivadeneira F., Hofman A., van Leeuwen J.P.T., Jehan F., Pols H.A.P., Uitterlinden A.G. Promoter and 3'-untranslated-region haplotypes in the vitamin D Receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am. J. Hum. Genet. 2005, 77:807-823.
23. Fetahu I.S., Höbaus J., Kállay E. Vitamin D and the epigenome. Front. Physiol. 2014, 5:164.
24. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1988, 124:869-871.
25. 3 through DNA methylation and histone modification. PLoS One 2013, 8:e61423.
26. Gardiner E.M., Esteban L.M., Fong C., Allison S.J., Flanagan J.L., Kouzmenko A.P., Eisman J.A. Vitamin D receptor B1 and exon 1d: functional and evolutionary analysis. J. Steroid Biochem. Mol. Biol. 2004, 89-90:233-238.
27. Gu X., Nylander E., Coates P.J., Nylander K. Effect of narrow-band ultraviolet B phototherapy on p63 and microRNA (miR-21 and miR-125b) expression in psoriatic epidermis. Acta Derm. Venereol. 2011, 91:392-397.
28. Haddad J.G., Matsuoka L.Y., Hollis B.W., Hu Y.Z., Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J. Clin. Invest. 1993, 91:2552-2555.
29. Hagenau T., Vest R., Gissel T.N., Poulsen C.S., Erlandsen M., Mosekilde L., Vestergaard P. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos. Int. 2009, 20:133-140.
30. Halsall J.A., Osborne J.E., Hutchinson P.E., Pringle J.H. In silico analysis of the 5' region of the Vitamin D receptor gene: functional implications of evolutionary conservation. J. Steroid Biochem. Mol. Biol. 2007, 103:352-356.
31. Haussler M.R., Whitfield G.K., Kaneko I., Haussler C.A., Hsieh D., Hsieh J.C., Jurutka P.W. Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 2013, 92:77-98.
32. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003, 77:204-210.
33. Hochberg Z., Templeton A.R. Evolutionary perspective in skin color, vitamin D and its receptor. Hormones 2010, 9:307-311.
34. Holick M.F. Vitamin D: a millennium perspective. J. Cell. Biochem. 2003, 88:296-307.
35. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 2004, 79:362-371.
36. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancer, and cardiovascular disease. Am. J. Clin. Nutr. 2004, 80:1678S-1688S.
37. Holick M.F., MacLaughlin J.A., Clark M.B., Holick S.A., Jr Potts J.T., Anderson R.R., Blank I.H., Parrish J.A., Elias P. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980, 10:203-205.
38. 3 in skin: an approach to the therapy of vitamin-D-resistant syndromes. N. Engl. J. Med. 1980, 303:349-354.
39. Kim M.-S., Kondo T., Takada I., Youn M.-Y., Yamamoto Y., Takahashi S., Matsumoto T., Fujiyama S., Shirode Y., Yamaoka I., Kitagawa H., Takeyama K.-I., Shibuya H., Ohtake F., Kato S. DNA demethylation in hormone-induced transcriptional de repression. Nature 2009, 461:1007-1012.
40. Kolasinska-Zwierz P., Down T., Latorre I., Liu T., Liu X.S., Ahringer J. Differential chromatin marking of introns and expressed exons by H3K36me3. Nat. Genet. 2009, 41:376-381.
41. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
42. Krasowski M.D., Yasuda K., Hagey L.R., Schuetz E.G. Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors). Nucl. Recept. 2005, 3:2.
43. Lamberg-Allardt C. Vitamin D in foods and as supplements. Prog. Biophys. Mol. Biol. 2006, 92:33-38.
44. Ledford H. Language: disputed definitions. Nature 2008, 455:1023-1028.
45. Li H., Stampfer M.J., Hollis J.B., Mucci L.A., Gaziano J.M., Hunter D., Giovannucci E.L., Ma J. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007, 4:e103.
46. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zügel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 24:1770-1773.
47. Loomis W.F. Skin-pigment regulation of vitamin D biosynthesis in man; variation in solar ultraviolet at different latitudes may have caused racial differentiation in man. Science 1967, 157:501-506.
48. López de Silanes I., Zhan M., Lal A., Yang X., Gorospe M. Identification of a target RNA motif for RNA-binding protein HuR. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2987-2992.
49. Luxwolda M.F., Kuipers R.S., Kema I.P., Dijck-Brouwer D.A., Muskiet F.A. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115nmol/l. Br. J. Nutr. 2012, 108:1557-1561.
50. 3 and its photoisomers in human skin. Science 1982, 216:1001-1003.
51. Marik R., Fackler M., Gabrielson E., Zeiger M.A., Sukumar S., Stearns V., Umbricht C.B. DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol. Ther. 2010, 10:1-10.
52. Matsuoka L.Y., Wortsman J., Dannenberg M.J., Hollis B.W., Lu Z., Holick M.F. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J. Clin. Endocrinol. Metab. 1992, 75:1099-1103.
53. Meyer M.B., Benkusky N.A., Lee C.H., Pike J.W. Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation. J. Biol. Chem. 2014, 289:19539-19554.
54. Miyamoto K., Kesterson R.A., Yamamoto H., Taketani Y., Nishiwaki E., Tatsumi S., Inoue Y., Morita K., Takeda E., Pike J.W. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endocrinol. 1997, 11:1165-1179.
55. Mohri T., Nakajima M., Takagi S., Komagata S., Yokoi T. MicroRNA regulates human vitamin D receptor. Int. J. Cancer 2009, 125:1328-1333.
56. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
57. Murayama A., Kim M., Kanagisawa J., Takeyama K., Kato S. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 2004, 23:1598-1608.
58. Norman A.W. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am. J. Clin. Nutr. 1998, 7:1108-1110.
59. Nowak R., Szota J., Mazurek U. Vitamin D receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of juvenile and adolescent idiopathic scoliosis patients. BMC Musculoskelet. Disord. 2012, 13:259.
60. Nowson C.A., Margerison C. Vitamin D intake and vitamin D status of Australians. Med. J. Aust. 2002, 177:149-152.
61. Nykjaer A., Dragun D., Walther D., Vorum H., Jacobsen C., Herz J., Melsen F., Christensen E.I., Willnow T.E. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999, 96:507-515.
62. Nykjaer A., Fyfe J.C., Kozyraki R., Leheste J.R., Jacobsen C., Nielsen M.S., Verroust P.J., Aminoff M., de la Chapelle A., Moestrup S.K., Ray R., Gliemann J., Willnow T.E., Christensen E.I. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13895-13900.
63. O'Neill V., Koorsen G., Bornman L. Epigenetika: die skakeltussengenetika en omgewing. Litnet Akad. 2012, 9:42-72.
64. Ogunkolade B.W., Boucher B.J., Prahl J.M., Bustin S.A., Burrin J.M., Noonan K., North B.V., Mannan N., McDermott M.F., DeLuca H.F., Hitman G.A. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002, 51:2294-2300.
65. Pan Y.-Z., Gao W., Yu A.-M. MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab. Dispos. 2009, 37:2112-2117.
66. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
67. Prentice A. Vitamin D deficiency: a global perspective. Nutr. Rev. 2008, 66:S153-S164.
68. Reschley E.J., Krasowski M.D. Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr. Drug Metab. 2006, 7:349-365.
69. Samuel S., Sitrin M.D. Vitamin D's role in cell proliferation and differentiation. Nutr. Rev. 2008, 66:S116-S124.
70. 3 level and expression of vitamin D receptor and cathelicidin in pulmonary tuberculosis. J. Clin. Immunol. 2009, 29:470-478.
71. Sinotte M., Diorio C., Bérubé S., Pollak M., Brisson J. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am. J. Clin. Nutr. 2009, 89:634-640.
72. Smirnoff P., Liel Y., Gnainsky J., Shany S., Schwartz B. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol. Res. 1999, 11:255-264.
73. Sundar I.K., Rahman I. Vitamin D and susceptibility of chronic lung diseases: role of epigenetics. Front. Pharmacol. 2011, 2:50.
74. Sunn K.L., Cock T.A., Crofts L.A., Eisman J.A., Gardiner E.M. Novel N-terminal variant of human VDR. Mol. Endocrinol. 2001, 15:1599-1609.
75. Tuoresmäki P., Väisänen S., Neme A., Heikkinen S., Carlberg C. Patterns of genome-wide VDR locations. PLoS One 2014, 9:e96105.
76. Vieth R., Chan P.C., MacFarlane G.D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr. 2001, 73:288-294.
77. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., Benjamin E.J., D'Agostino R.B., Wolf M., Vasan R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
78. Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., Kiel D.P., Streeten E.A., Ohlsson C., Koller D.L., Peltonen L., Cooper J.D., O'Reilly P.F., Houston D.K., Glazer N.L., Vandenput L., Peacock M., Shi J., Rivadeneira F., McCarthy M.I., Anneli P., de Boer I.H., Mangino M., Kato B., Smyth D.J., Booth S.L., Jacques P.F., Burke G.L., Goodarzi M., Cheung C.L., Wolf M., Rice K., Goltzman D., Hidiroglou N., Ladouceur M., Wareham N.J., Hocking L.J., Hart D., Arden N.K., Cooper C., Malik S., Fraser W.D., Hartikainen A.L., Zhai G., Macdonald H.M., Forouhi N.G., Loos R.J., Reid D.M., Hakim A., Dennison E., Liu Y., Power C., Stevens H.E., Jaana L., Vasan R.S., Soranzo N., Bojunga J., Psaty B.M., Lorentzon M., Foroud T., Harris T.B., Hofman A., Jansson J.O., Cauley J.A., Uitterlinden A.G., Gibson Q., Järvelin M.R., Karasik D., Siscovick D.S., Econs M.J., Kritchevsky S.B., Florez J.C., Todd J.A., Dupuis J., Hyppönen E., Spector T.D. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
79. White J.H. Vitamin D signalling, infectious diseases, and regulation of innate immunity. Infect. Immun. 2008, 76:3837-3843.
80. Whitfield G.K., Remus L.S., Jurutka P.W., Zitzer H., Oza A.K., Dang H.T., Haussler C.A., Galligan M.A., Thatcher M.L., Encinas Dominguez C., Haussler M.R. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol. Cell. Endocrinol. 2001, 177:145-159.
81. 3 results from ligand-induced stabilization. J. Biol. Chem. 1992, 267:20082-20086.
82. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., Wright D., Latif M., Davidson R.N. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case-control study. Lancet 2000, 355:618-621.
83. Young M.D., Willson T.A., Wakefield M.J., Trounson E., Hilton D.J., Blewitt M.E., Oshlack A., Majewski I.J. ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity. Nucleic Acids Res. 2011, 39:7415-7427.
84. 3-1α-hydroxylase. J. Clin. Endocrinol. Metab. 2001, 86:888-894.
85. 3. Mol. Endocrinol. 2006, 20:1231-1247.
86. Zella L.A., Kim S., Shevde N.K., Pike J.W. Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 2007, 103:435-439.
87. Zella L.A., Meyer M.B., Nerenz R.D., Lee S.M., Martowicz M.L., Pike J.W. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 2010, 24:128-147.